Premier Explosives Ltd Q4 FY2024 Concall Summary

Key Takeaways

• Revenue surged on export billing: Q4 revenue jumped exponentially as pending Israel export order revenue was received, pushing defense segment growth to 135% for the quarter.
• Order book nearly doubled: The order book grew 85% YoY to ~₹964 Crores, equivalent to 3.6x FY2024 revenue, giving the company the scale to bid for larger orders.
• Margins dipped on product mix: Gross margins declined in Q4 despite defense being the major revenue contributor; management attributed this to product mix variation but did not quantify the mix shift.
• Detonator business going to zero: The legacy detonator business, where quantities are capped by the regulator PESO, will drop to zero in FY2025, removing a revenue line entirely.
• What to watch next quarter: Whether the ₹700-800 crore bid pipeline converts at the expected 60-70% win rate, the pace of countermeasure billing in H1, and whether defense revenue mix actually reaches the targeted 75-80%.

Defense Order Book & Execution

• Order book composition: The ₹964 crore order book will be executed over approximately 2 years, except the ISRO order which runs over 6 years. The company expects to maintain the book in the ₹900-₹1,000 crore range.
• Countermeasure billing timeline: Billing started with small volume in March; a significant portion will be billed in H1 FY2025. The company hopes to complete the countermeasure order in the current financial year.
• Countermeasure continuity: Production and supply of countermeasures will continue at the same level for at least the next 4-5 years, with further orders expected.
• Rocket motors: The next lot was shipped in Q4 FY24; further billing depends on vessel availability. The company is the only Indian company specializing in export of fully assembled rocket motors.
• Nipun Mines: The first batch was supplied in April 2024; the balance order is scheduled for completion in FY2024-25.
• Chaffs & flares execution: Production is consistently ongoing but dispatches are lumpy because inspecting agencies do not come every month; the company must build stock and dispatch in tranches. Some quantity is expected in June.
• Geopolitical delays resolved: Delays caused in the last financial year by the macroeconomic and geopolitical scenario have now been resolved; supplies have started.

Chowdary: "Premier is the only qualified Indian company for counter measures, and the only Indian company which specializes in the export of fully assembled rocket motor."

Product Development Pipeline

• 40mm ammunition: Development of 40mm HEAP and HEDP ammunition for UBGL, HBGL and the DCPP program of DRDO has been successfully completed. The company expects to participate in RFPs from paramilitary forces and the Indian Army, with production and supplies expected to start in the current financial year.
• BrahMos status: Trials have been conducted and dynamic testing done; tests are good. The company has been asked to submit a quotation for the next production order. A bulk order will not come in the current year, but an enlarged quantity is expected, with about 50 numbers per annum as the anticipated volume.
• Rudram-II: The company is the propellant rocket motor manufacturer for Rudram-II, having received ToT from DRDO. As of now, they are the only ones, though others could also approach DRDO for the technology.
• Pinaka clarification: The company has taken ToT for Pinaka Mark-I and Mark-II, but is not in production and has no order. No immediate RFPs are expected as orders are being fulfilled by MIL and other companies.
• New business areas: The company wants to expand into filling bombs and artillery shells, which are new areas it is not currently in. Raw material production will support both export demand and these new filling operations.

Chowdary: "Right now, we are only there. But we can't tell. Others can also -- when it is a ToT from DRDL or DRDO, others also can approach and take them. But as on date, we are the only ones."

Bid Pipeline & Order Inflow

• Active bid pipeline: The company is participating in bids worth about ₹700-800 crore, with an expected win rate of 60-70%, implying at least ₹500 crore could materialize. Many bids are in the RFP stage with responses submitted and under consideration.
• Limited competition: The number of players in the company's segments is limited, which management believes positions it favorably for award decisions.
• Order inflow expectations: Countermeasures will continue; the company also expects inflow of orders for new rockets and missiles.
• BrahMos next steps: The company has been asked to submit a quotation for the next production order; management declined to quantify the value in rupee terms at this stage.
• Chaffs & flares pipeline: Further RFPs are in the pipeline beyond the current contract.

Margins & Financials

• Gross margin decline: Gross margins reduced in Q4 due to product mix; different products carry different margin profiles. Management did not explain why a defense-heavy mix (62% of revenue, up from 40% YoY) produced lower gross margins.
• EBITDA margin guidance: Margins are expected to remain in the 18%-21% range for FY2025, as the same business mix continues.
• Defense vs commercial margins: Defense margins are "a little better" than commercial explosives margins, but management declined to bifurcate or discuss specifics citing competitive sensitivity.
• Cash flow: Healthy cash profit was generated; improved cash flows will be used to strengthen the balance sheet. Increased operational leverage from the cost structure and steady execution will enhance cash flow generation.
• Working capital: With existing bank facilities and advances, the company is comfortable and can reach targets without additional working capital facilities.
• Imports: Imports were less than 10% of total revenue in FY2024, varying year-on-year and product-to-product.

Chowdary: "The margins will be in the same line because the same business will continue in the same way. Will be in the range of 18% - 20% - 21% of EBITDA for the year ending '25."

Capex & Capacity Expansion

• Capex focus areas: Investment will go into expanding raw material capacity (TNT, RDX, HMX), ammunition production, propellant production, and new areas in aerospace and ammunition.
• Odisha facility: The Odisha government has issued a letter to identify land for allotment; 4-5 land banks were shortlisted. The process was delayed by the election code and will restart from June, with allotment expected in 5-6 months. The first priority for the facility is TNT production, followed by filling of bombs and ammunitions.
• Existing capacity sufficient: Present order book execution can be handled by existing capacities; capex is for future orders and does not affect current production.
• Capex quantification deferred: Detailed capex numbers will be provided at a later date.
• Raw material export expansion: The company expects significant contribution from export of raw materials like TNT, RDX, and HMX, adding to present export income from rocket motors and warheads.

Revenue Mix & Segment Shifts

• Defense revenue mix: Defense contribution increased from 40% to 62% year-on-year, with a target of reaching 75-80% going forward.
• Detonator business phase-out: The detonator business will go to zero in FY2025. Quantities are not decided by the company but by PESO, which sets a limit; the company sells up to that limit.
• Commercial explosives: Expected to continue performing well in coming years despite the detonator phase-out.
• RDX and HMX exports: The company has started exporting RDX and HMX, opening a new revenue stream.
• Revenue guidance declined: Management normally does not give guidance; based on the existing order book and timeline, only "some good improvement" was indicated directionally.

Chowdary: "Detonators is a market which is going out. So the quantities are not decided by us. They are decided by PESO and they are giving a limit, and we are selling up to the limit we have given. So next financial year, it is going to be 0."

R&D & Technology

• R&D embedded in operations: R&D in explosives is not lab-based; safety interlocks and testing happen in production plants, so R&D expenditure cannot be separately identified and gets absorbed in regular operating costs.
• Academic collaborations: Associations with Gulbarga University, IIT Madras and BITS Pilani are for academic research in high energy materials, not direct product research. Product R&D is done in-house.
• R&D spend undisclosed: When asked about overall R&D spend apart from prototype spending, management did not provide a figure, instead discussing the nature of academic collaborations.

Chowdary: "See, this is -- these explosives and all those being dangerous and hazardous, they need a lot of safety mechanisms and the interlocks. So these things are done not in laboratory, but they are all done in the production plant itself because production plants are designed to have all those safety interlocks."

Guidance & Commitments

Key Metrics